Athira pharma to present at upcoming november investor conferences

Seattle, nov. 10, 2020 (globe newswire) -- athira pharma, inc. (nasdaq: atha), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration, today announced that dr. leen kawas, president and chief executive officer, and dr. hans moebius, chief medical officer, will participate in fireside chats at two upcoming investor conferences:
ATHA Ratings Summary
ATHA Quant Ranking